Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The remedē® System (Respiratory Rhythm Management™ Device) for the Treatment of Central Sleep Apnea in Daily Practice

NCT02577445 is registered in ClinicalTrials.gov with LivaNova as lead sponsor.

NCT NCT02577445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02577445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The remedē® System (Respiratory Rhythm Management™ Device) for the Treatment of Central Sleep Apnea in Daily Practice
Lead sponsor
LivaNova
Phase
Observational
Overall status
Terminated
Start date
February 29, 2016
Completion date
October 31, 2016
Enrollment
31 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

central sleep disordered breathing, sleep apnea